Comprehensive characterisation of compartment-specific long non-coding RNAs associated with pancreatic ductal adenocarcinoma

Objective Pancreatic ductal adenocarcinoma (PDA) is a highly metastatic disease with limited therapeutic options. Genome and transcriptome analyses have identified signalling pathways and cancer driver genes with implications in patient stratification and targeted therapy. However, these analyses were performed in bulk samples and focused on coding genes, which represent a small fraction of the genome. Design We developed a computational framework to reconstruct the non-coding transcriptome from cross-sectional RNA-Seq, integrating somatic copy number alterations (SCNA), common germline variants associated to PDA risk and clinical outcome. We validated the results in an independent cohort of paired epithelial and stromal RNA-Seq derived from laser capture microdissected human pancreatic tumours, allowing us to annotate the compartment specificity of their expression. We employed systems and experimental biology approaches to interrogate the function of epithelial long non-coding RNAs (lncRNAs) associated with genetic traits and clinical outcome in PDA. Results We generated a catalogue of PDA-associated lncRNAs. We showed that lncRNAs define molecular subtypes with biological and clinical significance. We identified lncRNAs in genomic regions with SCNA and single nucleotide polymorphisms associated with lifetime risk of PDA and associated with clinical outcome using genomic and clinical data in PDA. Systems biology and experimental functional analysis of two epithelial lncRNAs (LINC00673 and FAM83H-AS1) suggest they regulate the transcriptional profile of pancreatic tumour samples and PDA cell lines. Conclusions Our findings indicate that lncRNAs are associated with genetic marks of pancreatic cancer risk, contribute to the transcriptional regulation of neoplastic cells and provide an important resource to design functional studies of lncRNAs in PDA.

[1]  Jordan A. Ramilowski,et al.  An atlas of human long non-coding RNAs with accurate 5′ ends , 2017, Nature.

[2]  A. Feinberg,et al.  Epigenomic reprogramming during pancreatic cancer progression links anabolic glucose metabolism to distant metastasis , 2017, Nature Genetics.

[3]  Johannes G. Reiter,et al.  Limited heterogeneity of known driver gene mutations among the metastases of individual patients with pancreatic cancer , 2017, Nature Genetics.

[4]  Junjie Chen,et al.  RPA-Binding Protein ETAA1 Is an ATR Activator Involved in DNA Replication Stress Response , 2016, Current Biology.

[5]  A. Biankin,et al.  PDX1 dynamically regulates pancreatic ductal adenocarcinoma initiation and maintenance , 2016, Genes & development.

[6]  John M. Shelton,et al.  Transcription of the non-coding RNA upperhand controls Hand2 expression and heart development , 2016, Nature.

[7]  Jie Hong,et al.  Analysis of long non-coding RNA expression profiles in pancreatic ductal adenocarcinoma , 2016, Scientific Reports.

[8]  Xin Lu,et al.  Transcriptomic profiling of long non-coding RNAs in dermatomyositis by microarray analysis , 2016, Scientific Reports.

[9]  S. Aerts,et al.  p53 induces formation of NEAT1 lncRNA-containing paraspeckles that modulate replication stress response and chemosensitivity , 2016, Nature Medicine.

[10]  N. Malats,et al.  GATA6 regulates EMT and tumour dissemination, and is a marker of response to adjuvant chemotherapy in pancreatic cancer , 2016, Gut.

[11]  T. Tomonaga,et al.  FAM83H and casein kinase I regulate the organization of the keratin cytoskeleton and formation of desmosomes , 2016, Scientific Reports.

[12]  Wen Tan,et al.  Pancreatic cancer risk variant in LINC00673 creates a miR-1231 binding site and interferes with PTPN11 degradation , 2016, Nature Genetics.

[13]  Andrea Califano,et al.  ARACNe-AP: gene network reverse engineering through adaptive partitioning inference of mutual information , 2016, Bioinform..

[14]  Howard Y. Chang,et al.  Long Noncoding RNAs in Cancer Pathways. , 2016, Cancer cell.

[15]  Stefan Van Aelst,et al.  Melanoma addiction to the long non-coding RNA SAMMSON , 2016, Nature.

[16]  R. Gibbs,et al.  Genomic analyses identify molecular subtypes of pancreatic cancer , 2016, Nature.

[17]  Jing Wang,et al.  lncRNA NBR2 engages a metabolic checkpoint by regulating AMPK under energy stress , 2016, Nature Cell Biology.

[18]  L. Amundadottir.  Pancreatic Cancer Genetics , 2016, International journal of biological sciences.

[19]  Maite Huarte.  The emerging role of lncRNAs in cancer , 2015, Nature Medicine.

[20]  Jen Jen Yeh,et al.  Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma , 2015, Nature Genetics.

[21]  Michael R Green,et al.  The acinar differentiation determinant PTF1A inhibits initiation of pancreatic ductal adenocarcinoma , 2015, eLife.

[22]  Manal M. Hassan,et al.  Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer , 2015, Nature Genetics.

[23]  Michael A. Choti,et al.  Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets , 2015, Nature Communications.

[24]  Rui Liu,et al.  The lncRNA DEANR1 facilitates human endoderm differentiation by activating FOXA2 expression. , 2015, Cell reports.

[25]  S. Dhanasekaran,et al.  The landscape of long noncoding RNAs in the human transcriptome , 2015, Nature Genetics.

[26]  W. Huber,et al.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.

[27]  Hongzhe Li,et al.  A functional genomic approach identifies FAL1 as an oncogenic long noncoding RNA that associates with BMI1 and represses p21 expression in cancer. , 2014, Cancer cell.

[28]  D. Largaespada,et al.  PVT1 dependence in cancer with MYC copy-number increase , 2014, Nature.

[29]  Benjamin D. Smith,et al.  Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. , 2014, Cancer research.

[30]  Y. Mo,et al.  Long non-coding RNA UCA1 promotes breast tumor growth by suppression of p27 (Kip1) , 2014, Cell Death and Disease.

[31]  S. Gabriel,et al.  Pan-cancer patterns of somatic copy-number alteration , 2013, Nature Genetics.

[32]  J. Rinn,et al.  Pint lincRNA connects the p53 pathway with epigenetic silencing by the Polycomb repressive complex 2 , 2013, Genome Biology.

[33]  L. Stanton,et al.  The long noncoding RNA RMST interacts with SOX2 to regulate neurogenesis. , 2013, Molecular cell.

[34]  C. Wright,et al.  Nr5a2 maintains acinar cell differentiation and constrains oncogenic Kras-mediated pancreatic neoplastic initiation , 2013, Gut.

[35]  W. Shi,et al.  The Subread aligner: fast, accurate and scalable read mapping by seed-and-vote , 2013, Nucleic acids research.

[36]  J. Kocher,et al.  CPAT: Coding-Potential Assessment Tool using an alignment-free logistic regression model , 2013, Nucleic acids research.

[37]  K. Jensen,et al.  Identification of Sox9-dependent acinar-to-ductal reprogramming as the principal mechanism for initiation of pancreatic ductal adenocarcinoma. , 2012, Cancer cell.

[38]  Shane J. Neph,et al.  Systematic Localization of Common Disease-Associated Variation in Regulatory DNA , 2012, Science.

[39]  Nadav S. Bar,et al.  Landscape of transcription in human cells , 2012, Nature.

[40]  Sergio Verjovski-Almeida,et al.  Long noncoding intronic RNAs are differentially expressed in primary and metastatic pancreatic cancer , 2011, Molecular Cancer.

[41]  P. Spellman,et al.  Subtypes of Pancreatic Ductal Adenocarcinoma and Their Differing Responses to Therapy , 2011, Nature Medicine.

[42]  D. Srivastava,et al.  The Antiproliferative Action of Progesterone in Uterine Epithelium Is Mediated by Hand2 , 2011, Science.

[43]  M. Hebrok,et al.  KRAS, Hedgehog, Wnt and the twisted developmental biology of pancreatic ductal adenocarcinoma , 2010, Nature Reviews Cancer.

[44]  Cole Trapnell,et al.  Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. , 2010, Nature biotechnology.

[45]  M. Washington,et al.  Loss of FOXA1/2 is essential for the epithelial-to-mesenchymal transition in pancreatic cancer. , 2010, Cancer research.

[46]  Derek Y. Chiang,et al.  The landscape of somatic copy-number alteration across human cancers , 2010, Nature.

[47]  Jeannie T. Lee,et al.  Polycomb Proteins Targeted by a Short Repeat RNA to the Mouse X Chromosome , 2008, Science.

[48]  G. Parmigiani,et al.  Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses , 2008, Science.

[49]  Howard Y. Chang,et al.  Functional Demarcation of Active and Silent Chromatin Domains in Human HOX Loci by Noncoding RNAs , 2007, Cell.

[50]  William Stafford Noble,et al.  Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project , 2007, Nature.

[51]  J. Mesirov,et al.  GenePattern 2.0 , 2006, Nature Genetics.

[52]  Adam A. Margolin,et al.  Reverse engineering of regulatory networks in human B cells , 2005, Nature Genetics.

[53]  Michael Thomas,et al.  MALAT-1, a novel noncoding RNA, and thymosin β4 predict metastasis and survival in early-stage non-small cell lung cancer , 2003, Oncogene.

[54]  N. Lemoine,et al.  Pancreatic Cancer Genetics , 2001, Pancreatology.

[55]  A. Jemal,et al.  Cancer statistics, 2017 , 2017, CA: a cancer journal for clinicians.

[56]  R. Liu,et al.  The lncRNA DEANR 1 Facilitates Human Endoderm Differentiation by Activating FOXA 2 Expression , 2015 .

[57]  Raffaele Pezzilli,et al.  Common variation at 2 p 13 . 3 , 3 q 29 , 7 p 13 and 17 q 25 . 1 associated with susceptibility to pancreatic cancer , 2022 .